Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
33.10
-0.40 (-1.19%)
Aug 1, 2025, 5:04 PM CET
-1.19%
Market Cap607.57M
Revenue (ttm)359.79M
Net Income (ttm)-4.95M
Shares Out18.36M
EPS (ttm)-0.27
PE Ration/a
Forward PE24.03
Dividendn/a
Ex-Dividend Daten/a
Volume50,077
Average Volume70,665
Open33.40
Previous Close33.50
Day's Range32.80 - 34.70
52-Week Range26.50 - 68.90
Beta0.01
RSI56.08
Earnings DateSep 12, 2025

About Verve Therapeutics

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.